Index by author
Abe, O.
- FELLOWS' JOURNAL CLUBHead & NeckOpen AccessMRI Findings of Immune Checkpoint Inhibitor–Induced Hypophysitis: Possible Association with FibrosisR. Kurokawa, Y. Ota, W. Gonoi, A. Hagiwara, M. Kurokawa, H. Mori, E. Maeda, S. Amemiya, Y. Usui, N. Sato, Y. Nakata, T. Moritani and O. AbeAmerican Journal of Neuroradiology September 2020, 41 (9) 1683-1689; DOI: https://doi.org/10.3174/ajnr.A6692
This retrospective international multicenter study comprised 20 patients with melanoma who were being treated with immune checkpoint inhibitors and clinically diagnosed with immune checkpoint inhibitor–induced hypophysitis. Three radiologists evaluated the following MR imaging findings: enlargement of the pituitary gland and stalk; homogeneity of enhancement of the pituitary gland; presence/absence of a well-defined poorly enhanced area and, if present, its location, shape, and signal intensity in T2WI; and enhancement pattern in contrast-enhanced dynamic MR imaging. Enlargement of the pituitary gland and stalk was observed in 12 and 20 patients, respectively. Nineteen patients showed poorly enhanced lesions (geographic hypoenhancing lesions) in the anterior lobe, and 11 of these lesions showed hypointensity on T2WI. Thyrotropin deficiency and corticotropin deficiency were observed in 19/20 and 12/17 patients, respectively. The authors conclude that pituitary geographic hypoenhancing lesions in the anterior lobe of the pituitary gland are characteristic and frequent MR imaging findings of immune checkpoint inhibitor–induced hypophysitis.
Almeida, L.
- Adult BrainOpen AccessNeuroimaging Advances in Deep Brain Stimulation: Review of Indications, Anatomy, and Brain ConnectomicsE.H. Middlebrooks, R.A. Domingo, T. Vivas-Buitrago, L. Okromelidze, T. Tsuboi, J.K. Wong, R.S. Eisinger, L. Almeida, M.R. Burns, A. Horn, R.J. Uitti, R.E. Wharen, V.M. Holanda and S.S. GrewalAmerican Journal of Neuroradiology September 2020, 41 (9) 1558-1568; DOI: https://doi.org/10.3174/ajnr.A6693
Amemiya, S.
- FELLOWS' JOURNAL CLUBHead & NeckOpen AccessMRI Findings of Immune Checkpoint Inhibitor–Induced Hypophysitis: Possible Association with FibrosisR. Kurokawa, Y. Ota, W. Gonoi, A. Hagiwara, M. Kurokawa, H. Mori, E. Maeda, S. Amemiya, Y. Usui, N. Sato, Y. Nakata, T. Moritani and O. AbeAmerican Journal of Neuroradiology September 2020, 41 (9) 1683-1689; DOI: https://doi.org/10.3174/ajnr.A6692
This retrospective international multicenter study comprised 20 patients with melanoma who were being treated with immune checkpoint inhibitors and clinically diagnosed with immune checkpoint inhibitor–induced hypophysitis. Three radiologists evaluated the following MR imaging findings: enlargement of the pituitary gland and stalk; homogeneity of enhancement of the pituitary gland; presence/absence of a well-defined poorly enhanced area and, if present, its location, shape, and signal intensity in T2WI; and enhancement pattern in contrast-enhanced dynamic MR imaging. Enlargement of the pituitary gland and stalk was observed in 12 and 20 patients, respectively. Nineteen patients showed poorly enhanced lesions (geographic hypoenhancing lesions) in the anterior lobe, and 11 of these lesions showed hypointensity on T2WI. Thyrotropin deficiency and corticotropin deficiency were observed in 19/20 and 12/17 patients, respectively. The authors conclude that pituitary geographic hypoenhancing lesions in the anterior lobe of the pituitary gland are characteristic and frequent MR imaging findings of immune checkpoint inhibitor–induced hypophysitis.
Amrhein, T.J.
- Spine Imaging and Spine Image-Guided InterventionsYou have accessRespiratory Phase Affects the Conspicuity of CSF–Venous Fistulas in Spontaneous Intracranial HypotensionT.J. Amrhein, L. Gray, M.D. Malinzak and P.G. KranzAmerican Journal of Neuroradiology September 2020, 41 (9) 1754-1756; DOI: https://doi.org/10.3174/ajnr.A6663
Aoki, S.
- EDITOR'S CHOICEAdult BrainOpen AccessMyelin and Axonal Damage in Normal-Appearing White Matter in Patients with Moyamoya DiseaseS. Hara, M. Hori, A. Hagiwara, Y. Tsurushima, Y. Tanaka, T. Maehara, S. Aoki and T. NariaiAmerican Journal of Neuroradiology September 2020, 41 (9) 1618-1624; DOI: https://doi.org/10.3174/ajnr.A6708
Eighteen patients with Moyamoya disease (16–55 years of age) and 18 age- and sex-matched healthy controls were evaluated with myelin-sensitive MR imaging based on magnetization transfer saturation imaging and 2-shell diffusion MR imaging. The myelin volume fraction, which reflects the amount of myelin sheath; the g-ratio, which represents the ratio of the inner (axon) to the outer (axon plus myelin) diameter of the fiber; and the axon volume fraction, which reflects axonal components, were calculated and compared between the patients and controls. Compared with the healthy controls, the patients with Moyamoya disease showed a significant decrease in the myelin and axon volume fractions in many WM regions, while the increases in the g-ratio values were not statistically significant. Correlations with cognitive performance were most frequently observed with the axon volume fraction. The authors conclude that the relationship with cognitive performance might be stronger with axonal damage than with myelin damage.
Aragao, M.F.V.V.
- Head & NeckOpen AccessAnosmia in COVID-19 Associated with Injury to the Olfactory Bulbs Evident on MRIM.F.V.V. Aragão, M.C. Leal, O.Q. Cartaxo Filho, T.M. Fonseca and M.M. ValençaAmerican Journal of Neuroradiology September 2020, 41 (9) 1703-1706; DOI: https://doi.org/10.3174/ajnr.A6675
Arnold, D.L.
- Adult BrainYou have accessPatterning Chronic Active Demyelination in Slowly Expanding/Evolving White Matter MS LesionsC. Elliott, D.L. Arnold, H. Chen, C. Ke, L. Zhu, I. Chang, E. Cahir-McFarland, E. Fisher, B. Zhu, S. Gheuens, M. Scaramozza, V. Beynon, N. Franchimont, D.P. Bradley and S. BelachewAmerican Journal of Neuroradiology September 2020, 41 (9) 1584-1591; DOI: https://doi.org/10.3174/ajnr.A6742
Arora, R.
- Adult BrainOpen AccessNeurovascular Complications in COVID-19 Infection: Case SeriesA.M. Franceschi, R. Arora, R. Wilson, L. Giliberto, R.B. Libman and M. CastilloAmerican Journal of Neuroradiology September 2020, 41 (9) 1632-1640; DOI: https://doi.org/10.3174/ajnr.A6655
Arquizan, C.
- FELLOWS' JOURNAL CLUBInterventionalYou have accessPredictors of Favorable Outcome after Endovascular Thrombectomy in MRI: Selected Patients with Acute Basilar Artery OcclusionM. Mahmoudi, C. Dargazanli, F. Cagnazzo, I. Derraz, C. Arquizan, A. Wacogne, J. Labreuche, A. Bonafe, D. Sablot, P.H. Lefevre, G. Gascou, N. Gaillard, C. Scott, V. Costalat and I. MourandAmerican Journal of Neuroradiology September 2020, 41 (9) 1670-1676; DOI: https://doi.org/10.3174/ajnr.A6741
The authors analyzed consecutive MR imaging–selected patients with acute basilar artery occlusions endovascularly treated within the first 24 hours after symptom onset. Successful and complete reperfusion was defined as modified TICI scores 2b–3 and 3, respectively. Outcome at 90 days was analyzed. One hundred ten patients were included. In 10 patients, endovascular treatment was aborted for failed proximal/distal access. Overall, successful reperfusion was achieved in 81.8% of cases. At 90 days, favorable outcome was 31.8%, with a mortality rate of 40.9%; the prevalence of symptomatic intracranial hemorrhage within 24 hours was 2.7%. The median time from symptom onset to groin puncture was 410 minutes. In this series of MR imaging–selected patients with acute basilar artery occlusions, complete reperfusion was the strongest predictor of a good outcome. Lower pretreatment NIHSS, the presence of posterior communicating artery collateral flow, the absence of atrial fibrillation, and intravenous thrombolysis administration were associated with favorable outcome.
Baek, J.H.
- Adult BrainYou have accessThin-Section MR Imaging for Carotid Cavernous FistulaD. Kim, Y.J. Choi, Y. Song, S.R. Chung, J.H. Baek and J.H. LeeAmerican Journal of Neuroradiology September 2020, 41 (9) 1599-1605; DOI: https://doi.org/10.3174/ajnr.A6757
- Head and Neck ImagingYou have accessDiagnostic Accuracy of MRI-Based Morphometric Parameters for Detecting Olfactory Nerve DysfunctionM.K. Lee, J.H. Lee, J.H. Kim, H. Kim, L. Joo, M. Kim, S.J. Cho, C.H. Suh, S.R. Chung, Y.J. Choi and J.H. BaekAmerican Journal of Neuroradiology September 2020, 41 (9) 1698-1702; DOI: https://doi.org/10.3174/ajnr.A6697